Phase 2 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are pregnant with a single baby and are less than 16 weeks along, with the pregnancy dates confirmed by ultrasound
- People who have at least one high-risk factor for preeclampsia (a serious condition involving high blood pressure in pregnancy), or at least two moderate risk factors, as defined by United States health guidelines from 2021
- People for whom a doctor has recommended taking 162mg of aspirin daily during pregnancy
- People who are between 16 and 55 years old
Who may not be able to join:
- People who have a medical reason why they cannot take aspirin
- People who are currently using or planning to use any blood-thinning medication other than aspirin
- People who have a low platelet count, or any known condition affecting platelets or blood clotting
- People who had an abnormal result on a specific blood clotting test (called a PFA-100 epinephrine closure time test) before starting aspirin (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 215-955-5000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Aspirin Response PFA-100 epinephrine closure time (seconds)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.